COVISHIELD phase 2, 3 trials get DCGI nod
News: Drugs Controller General of India(DCGI) has given approval to Serum Institute of India(SII) to conduct Phase II+III clinical trials of Oxford University AstraZeneca COVID-19 vaccine(COVISHIELD). Facts: COVISHIELD: The Oxford …
Read More